Zelrix is a transdermal patch NUPATH designed to cure headaches. NUPATH designed this patch recently accepted by the Food and Drug Administration (FDA) for tests until 29 August 2011. This is a single-use disposable patch-based technology called transdermal iontophoretic SmartRelief. This is to deliver the sumatripan, an anti-migraine, through the skin with a mild electric charge. NUPATH ad that "This not only enables a more consistent and controlled delivery of the drug, but it also circumvents the nausea and vomiting that may occur while taking the drug orally."
Go to the end of the period of experimentation to find the first conclusions on Zelrix.
via tomsguide.fr
0 comments:
Post a Comment